Skip to main content
. 2012 Sep;72(9):819–832. doi: 10.1055/s-0032-1315340

Table 1 Therapy recommendations of the recent St. Gallen Consensus 8. (ET: endocrine therapy; CT: chemotherapy; Anti-HER2: anti-HER2 therapy).

Subtype Therapy
Luminal A ET
Luminal B (HER2 negative) ET ± CT (“after risk assessment”)
Luminal B (HER2 positive) CT + Anti-HER2 + ET
HER2 positive (non-luminal) CT + Anti-HER2
Triple negative CT